Skip to main content
SpringerLink
Log in

Prognostic value of amyloid PET scan in normal pressure hydrocephalus

Journal of Neurology volume 265, pages 63–73 (2018)Cite this article

Abstract

Amyloid positron emission tomography ([18F] florbetaben (FBB) PET) can be used to determine concomitant Alzheimer’s disease (AD) in idiopathic normal pressure hydrocephalus (iNPH) patients. FBB PET scans and the tap test were performed in 31 patients with clinically suspected iNPH, and amyloid positive (iNPH/FBB+) and negative (iNPH/FBB−) groups were compared with respect to clinical characteristics. We evaluated prognostic value of FBB PET scans by analyzing the response to the tap test using a linear mixed model. We also performed a multivariable regression analysis to investigate whether amyloid PET positivity can predict the positive tap test response independent of other AD biomarkers. The results showed that the iNPH/FBB+ group (7/31, 22.6%) had a higher percentage of APOE4 carriers, lower Aβ42, higher CSF t-tau, and p-tau/Aβ42 ratio than the iNPH/FBB− group (24/31, 77.4%), while the two groups did not differ in imaging characteristics. The iNPH/FBB− group had a higher percentage of tap responders and showed a greater improvement in gait scores after the tap test than the iNPH/FBB+ group (group-tap test effect interaction, p = 0.035). A multivariable logistic regression analysis showed that amyloid positivity on PET scans (OR 0.03, p = 0.029) and CSF p-tau (OR 0.87, p = 0.044) were independently associated with the positive tap test response. Among 21 tap responders in the iNPH/FBB− group, 14 patients received shunt surgery and 12/14 (85.7%) patients showed symptom improvement. Our findings suggest that amyloid PET scans can help determine which iNPH patients will benefit from shunt surgery by discriminating concomitant AD.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM (2005) Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery 57:S4–16 (discussion ii–v)

    Article  PubMed  Google Scholar 

  2. Malm J, Graff-Radford NR, Ishikawa M, Kristensen B, Leinonen V, Mori E, Owler BK, Tullberg M, Williams MA, Relkin NR (2013) Influence of comorbidities in idiopathic normal pressure hydrocephalus—research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS 10:22

    Article  PubMed  PubMed Central  Google Scholar 

  3. Savolainen S, Paljarvi L, Vapalahti M (1999) Prevalence of Alzheimer’s disease in patients investigated for presumed normal pressure hydrocephalus: a clinical and neuropathological study. Acta Neurochir (Wien) 141:849–853

    Article  CAS  Google Scholar 

  4. Golomb J, Wisoff J, Miller DC, Boksay I, Kluger A, Weiner H, Salton J, Graves W (2000) Alzheimer’s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry 68:778–781

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Del Bigio MR, Cardoso ER, Halliday WC (1997) Neuropathological changes in chronic adult hydrocephalus: cortical biopsies and autopsy findings. Can J Neurol Sci 24:121–126

    Article  PubMed  Google Scholar 

  6. Golomb J, Wisoff J, Miller D, Boksay I, Kluger A, Weiner H, Salton J, Graves W (2000) Alzheimer’s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry 68:778–781

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. O’Keeffe ST, Kazeem H, Philpott RM, Playfer JR, Gosney M, Lye M (1996) Gait disturbance in Alzheimer’s disease: a clinical study. Age Ageing 25:313–316

    Article  PubMed  Google Scholar 

  8. Hiraoka K, Narita W, Kikuchi H, Baba T, Kanno S, Iizuka O, Tashiro M, Furumoto S, Okamura N, Furukawa K, Arai H, Iwata R, Mori E, Yanai K (2015) Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus. J Neurol Sci 356:124–128

    Article  CAS  PubMed  Google Scholar 

  9. Kazui H, Kanemoto H, Yoshiyama K, Kishima H, Suzuki Y, Sato S, Suehiro T, Azuma S, Yoshimine T, Tanaka T (2016) Association between high biomarker probability of Alzheimer’s disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci 369:236–241

    Article  CAS  PubMed  Google Scholar 

  10. Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A, Shaw LM, Xie SX, Grady MS, Trojanowski JQ (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68:535–540

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lim TS, Choi JY, Park SA, Youn YC, Lee HY, Kim BG, Joo IS, Huh K, Moon SY (2014) Evaluation of coexistence of Alzheimer’s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers. BMC Neurol 14:66

    Article  PubMed  PubMed Central  Google Scholar 

  12. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW Jr, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60:1696–1702

    Article  PubMed  Google Scholar 

  13. Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF A beta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60:652–656

    Article  CAS  PubMed  Google Scholar 

  14. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ, Alzheimer’s Disease Neuroimaging I (2009) Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann Neurol 65:403–413

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kapaki EN, Paraskevas GP, Tzerakis NG, Sfagos C, Seretis A, Kararizou E, Vassilopoulos D (2007) Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer’s disease. Eur J Neurol 14:168–173

    Article  CAS  PubMed  Google Scholar 

  16. Jeppsson A, Holtta M, Zetterberg H, Blennow K, Wikkelso C, Tullberg M (2016) Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 13:13

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Graff-Radford NR (2014) Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus. Neurology 83:1573–1575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, Smith A, McLain R, Sherwin PF, Farrar G, Kailajarvi M, Grachev ID (2012) [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid beta detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathol 124:833–845

    Article  CAS  PubMed  Google Scholar 

  19. Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O, Grp FS (2011) Cerebral amyloid-beta PET with florbetaben (F-18) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10:424–435

    Article  CAS  PubMed  Google Scholar 

  20. Kondo M, Tokuda T, Itsukage M, Kuriyama N, Matsushima S, Yamada K, Nakanishi H, Ishikawa M, Nakagawa M (2013) Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer’s disease. Neuroradiol J 26:41–46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Leinonen V, Rinne JO, Virtanen KA, Eskola O, Rummukainen J, Huttunen J, von Und Zu, Fraunberg M, Nerg O, Koivisto AM, Rinne J, Jaaskelainen JE, Buckley C, Smith A, Jones PA, Sherwin P, Farrar G, McLain R, Kailajarvi M, Heurling K, Grachev ID (2013) Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients. Eur J Neurol 20:1043–1052

    Article  CAS  PubMed  Google Scholar 

  22. Wong DF, Moghekar AR, Rigamonti D, Brasic JR, Rousset O, Willis W, Buckley C, Smith A, Gok B, Sherwin P, Grachev ID (2013) An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Mol Imaging Biol 15:230–237

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kubo Y, Kazui H, Yoshida T, Kito Y, Kimura N, Tokunaga H, Ogino A, Miyake H, Ishikawa M, Takeda M (2008) Validation of grading scale for evaluating symptoms of idiopathic normal-pressure hydrocephalus. Dement Geriatr Cogn Disord 25:37–45

    Article  PubMed  Google Scholar 

  24. Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148

    Article  CAS  PubMed  Google Scholar 

  25. Schmidt H, Elster J, Eckert I, Wiefek J, Paulus W, von Steinbuechel N, Abatih E, Blocher J (2014) Cognitive functions after spinal tap in patients with normal pressure hydrocephalus. J Neurol 261:2344–2350

    Article  CAS  PubMed  Google Scholar 

  26. Van Swieten J, Koudstaal P, Visser M, Schouten H, Van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607

    Article  PubMed  Google Scholar 

  27. Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL (2010) Seoul neuropsychological screening battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 25:1071–1076

    Article  PubMed  PubMed Central  Google Scholar 

  28. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43:1683–1689

    Article  CAS  PubMed  Google Scholar 

  29. Barthel H, Luthardt J, Becker G, Patt M, Hammerstein E, Hartwig K, Eggers B, Sattler B, Schildan A, Hesse S, Meyer PM, Wolf H, Zimmermann T, Reischl J, Rohde B, Gertz HJ, Reininger C, Sabri O (2011) Individualized quantification of brain beta-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer’s disease and healthy controls. Eur J Nucl Med Mol Imaging 38:1702–1714

    Article  CAS  PubMed  Google Scholar 

  30. Virhammar J, Laurell K, Cesarini KG, Larsson EM (2014) Preoperative prognostic value of MRI findings in 108 patients with idiopathic normal pressure hydrocephalus. AJNR Am J Neuroradiol 35:2311–2318

    Article  CAS  PubMed  Google Scholar 

  31. Hashimoto M, Ishikawa M, Mori E, Kuwana N, Study of Inph on neurological improvement (2010) Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 7:18

    Article  PubMed  PubMed Central  Google Scholar 

  32. Patel S, Lee EB, Xie SX, Law A, Jackson EM, Arnold SE, Clark CM, Shaw LM, Grady MS, Trojanowski JQ, Hamilton RH (2012) Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 9:7

    Article  PubMed  PubMed Central  Google Scholar 

  33. Mirra SS, Heyman A, McKeel D, Sumi S, Crain BJ, Brownlee L, Vogel F, Hughes J, Van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479

    Article  CAS  PubMed  Google Scholar 

  34. Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O’Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, Rowe CC (2011) Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med 52:1210–1217

    Article  PubMed  Google Scholar 

  35. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2:506–511

    Article  PubMed  Google Scholar 

  36. Serot JM, Zmudka J, Jouanny P (2012) A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer’s disease. J Alzheimers Dis 30:17–26

    CAS  PubMed  Google Scholar 

  37. Kalaria RN, Premkumar DR, Pax AB, Cohen DL, Lieberburg I (1996) Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer’s disease. Brain Res Mol Brain Res 35:58–68

    Article  CAS  PubMed  Google Scholar 

  38. Buerger K, Ewers M, Pirttila T, Zinkowski R, Alafuzoff I, Teipel SJ, DeBernardis J, Kerkman D, McCulloch C, Soininen H, Hampel H (2006) CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer’s disease. Brain 129:3035–3041

    Article  PubMed  Google Scholar 

  39. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie T, Dickinson K, Maruff P, Darby D (2007) Imaging β-amyloid burden in aging and dementia. Neurology 68:1718–1725

    Article  CAS  PubMed  Google Scholar 

  40. Benzel EC, Pelletier AL, Levy PG (1990) Communicating hydrocephalus in adults: prediction of outcome after ventricular shunting procedures. Neurosurgery 26:655–660

    Article  CAS  PubMed  Google Scholar 

  41. Klinge P, Marmarou A, Bergsneider M, Relkin N, Black PM (2005) Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients. Neurosurgery 57:S40–52 (discussion ii–v)

    Article  PubMed  Google Scholar 

  42. Reinprecht A, Czech T, Dietrich W (1995) Clinical experience with a new pressure-adjustable shunt valve. Acta Neurochir (Wien) 134:119–124

    Article  CAS  Google Scholar 

  43. Raftopoulos C, Massager N, Baleriaux D, Deleval J, Clarysse S, Brotchi J (1996) Prospective analysis by computed tomography and long-term outcome of 23 adult patients with chronic idiopathic hydrocephalus. Neurosurgery 38:51–59

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-dong, Gangnam-gu, Seoul, 06351, Republic of Korea

    Hyemin Jang, Seong Beom Park, Yeshin Kim, Ko Woon Kim, Yeong Sim Choe, Sang Won Seo, Hee Jin Kim & Duk L. Na

  2. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Jung Il Lee

  3. Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Sung Tae Kim

  4. Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Kyung Han Lee

  5. Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    Eun-Suk Kang

  6. Neuroscience Center, Samsung Medical Center, Seoul, Korea

    Hyemin Jang, Yeshin Kim, Ko Woon Kim, Sang Won Seo, Hee Jin Kim & Duk L. Na

  7. Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea

    Sang Won Seo & Duk L. Na

  8. Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea

    Yeo Jin Kim

  9. Department of Neurology, Inha University School of Medicine, Incheon, Korea

    Cindy W. Yoon

  10. Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, Korea

    Duk L. Na

Authors
  1. Hyemin Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seong Beom Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yeshin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ko Woon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jung Il Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sung Tae Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kyung Han Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eun-Suk Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yeong Sim Choe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sang Won Seo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hee Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yeo Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Cindy W. Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Duk L. Na
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HJ: design of the study, acquisition and analysis of the data, and drafting the manuscript. YK, KWK, YJK, CWY: acquisition and interpretation of the data. STK, KHL: acquisition of the data. SWS, HJK: design of the study and interpretation of the data. DLN: design of the study, acquisition and analysis of the data, interpretation of the data, revising the manuscript, and study supervision. SBP, YSC: imaging data analysis

Corresponding author

Correspondence to Duk L. Na.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interests.

Study funding

This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3484), the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2746), and the B. Braun Korea.

Ethical standards

The study was approved by the Institutional Review Board of Samsung Medical Center. Written informed consent was obtained from all patients.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 1317 kb)

Supplementary material 2 (DOCX 1345 kb)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jang, H., Park, S.B., Kim, Y. et al. Prognostic value of amyloid PET scan in normal pressure hydrocephalus. J Neurol 265, 63–73 (2018). https://doi.org/10.1007/s00415-017-8650-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-017-8650-5

Keywords

search

Navigation